Building private-public sector capabilities to transition from supply-driven to demand-driven markets for ACT . SuNMaP

Document Type: Policy and technical briefs
Publication Date: 2014

SuNMaP incorporated an experimental project component, which focused on the development of private sector markets for long lasting insecticidal nets (LLINs), Artemisinin combination therapies (ACTs) and rapid diagnostic tests (RDTs). This case study describes how the evolution of the programme interventions have contributed to building the private and public sector capacities to transition from a supply-driven to demand-driven model for ACT. In fitting with the Making Markets Work for the Poor (M4P) approach this evolutionary way of implementation allowed SuNMaP to continually align its support in ACT market development with the needs and priorities of the market place. This case study underlined the key challenges and lessons in the design and implementation of similar interventions for developing sustainable commercial markets for the production, sale and distribution of malaria commodities.

The Support to National Malaria Programme (SuNMaP) funded by UK aid in Nigeria provided support to the National Malaria Elimination Programme (NMEP) and participating states to deliver malaria control services. The focus of SuNMaP malaria control initiatives was supporting both public and private sector to reduce the burden of malaria through different interventions in prevention and treatment that build capacity and strengthen service delivery for the entire population. As well as putting systems in place to ensure sustainable service delivery, the programme striveds to achieve behavioural change through sustained advocacy and public enlightenment on measures for effective malaria prevention and treatment at household level.



Download the case study (365kb)

Tags: Nigeria, Public-private partnerships, Malaria, private sector, vector control, malaria control, malaria prevention, malaria treatment., ACT., long-lasting insecticidal nets, LLINs, rapid diagnostic tests, malaria control services, PPPs, commercial sector, Artmesinin combination therapies, RDTs,